Nasal Glucagon
Nasal Glucagon is a pharmaceutical drug with 9 clinical trials. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
Clinical Trials (9)
A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults
A Study of Nasal Glucagon in Participants With a Common Cold
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9